Reaction Details |
| Report a problem with these data |
Target | Neuropeptide Y receptor type 5 |
---|
Ligand | BDBM50145235 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEBML_144155 |
---|
IC50 | 2±n/a nM |
---|
Citation | Rueeger, H; Gerspacher, M; Buehlmayer, P; Rigollier, P; Yamaguchi, Y; Schmidlin, T; Whitebread, S; Nuesslein-Hildesheim, B; Nick, H; Cricione, L Discovery and SAR of potent, orally available and brain-penetrable 5,6-dihydro-4H-3-thia-1-aza-benzo[e]azulen- and 4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulen derivatives as neuropeptide Y Y5 receptor antagonists. Bioorg Med Chem Lett14:2451-7 (2004) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Neuropeptide Y receptor type 5 |
---|
Name: | Neuropeptide Y receptor type 5 |
Synonyms: | NPY-Y5 | NPY-Y5 receptor | NPY5-R | NPY5R | NPY5R_HUMAN | NPYR5 | NPYY5 | Neuropeptide Y receptor type 5 | Neuropeptide Y receptor type 5 ( NPY Y5) | Y5 receptor |
Type: | Enzyme |
Mol. Mass.: | 50746.64 |
Organism: | Homo sapiens (Human) |
Description: | Q15761 |
Residue: | 445 |
Sequence: | MDLELDEYYNKTLATENNTAATRNSDFPVWDDYKSSVDDLQYFLIGLYTFVSLLGFMGNL
LILMALMKKRNQKTTVNFLIGNLAFSDILVVLFCSPFTLTSVLLDQWMFGKVMCHIMPFL
QCVSVLVSTLILISIAIVRYHMIKHPISNNLTANHGYFLIATVWTLGFAICSPLPVFHSL
VELQETFGSALLSSRYLCVESWPSDSYRIAFTISLLLVQYILPLVCLTVSHTSVCRSISC
GLSNKENRLEENEMINLTLHPSKKSGPQVKLSGSHKWSYSFIKKHRRRYSKKTACVLPAP
ERPSQENHSRILPENFGSVRSQLSSSSKFIPGVPTCFEIKPEENSDVHELRVKRSVTRIK
KRSRSVFYRLTILILVFAVSWMPLHLFHVVTDFNDNLISNRHFKLVYCICHLLGMMSCCL
NPILYGFLNNGIKADLVSLIHCLHM
|
|
|
BDBM50145235 |
---|
n/a |
---|
Name | BDBM50145235 |
Synonyms: | CHEMBL432169 | {4-[(9-Fluoro-5,6-dihydro-4H-3-thia-1-aza-benzo[e]azulen-2-ylamino)-methyl]-piperidin-1-yl}-(S)-tetrahydro-furan-2-yl-methanone |
Type | Small organic molecule |
Emp. Form. | C23H28FN3O2S |
Mol. Mass. | 429.551 |
SMILES | Fc1ccc2CCCc3sc(NCC4CCN(CC4)C(=O)[C@@H]4CCCO4)nc3-c2c1 |
Structure |
|